|
|
|
| home > pmps > spring 2004 > building a healthier system: improving efficiency and safety in the pharmaceutical supply chain |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
A question frequently asked of the industry reflects on how we can be sure that the pharmaceutical products sold by retailers have been sourced from a reputable and reliable company. Increasingly the answer to that question is: radio frequency identification (RFID), which offers a new technological solution for manufacturers and distributors. RFID tags are safe, secure, read only chips that can be used to improve the integrity and security of the pharmaceutical supply chain. The chips contain a unique electronic code for each individual item, which makes it far harder for counterfeiters to infiltrate legitimate distribution and the retail supply chain.
Pharmaceutical companies increasingly recognise the importance of traceability and due diligence within the pharmaceutical supply chain. There is a clear need for technological solutions that can prevent the misdirection of drugs and can stop counterfeit products from entering the legitimate pharmaceutical supply chain. RFID tags can help mitigate the risks associated with the production and distribution of pharmaceuticals goods. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
10th-Anniversary Event RFID Journal LIVE! 2012
3-5 April 2012, Walt Disney World Swan and Dolphin Resort, Orlando, Florida
RFID Journal LIVE! 2012, our tenth annual conference and exhibition, is the only event where you can learn how to use RFID technologies to improve your pharmaceutical and medical packaging business, from real-world case studies across all applications, including asset tracking, logistics and transportation, supply chain management, warehouse and inventory management, security and more. Learn from a customized program featuring more than 50 end-user case studies and 8 industry-specific and how-to conference tracks.
More info >> |
|
 |
News and Press Releases |
 |
Norwich Expands Capabilities for Phase I-III Clinical Trials
Norwich Clinical Services (NCS), a global provider of clinical research services for the pharmaceutical and biotech industries, today announced a significant expansion to its clinical research capabilities in order to meet growing market demand. Primary to the expansion, NCS unveiled a new clinical facility with capabilities to conduct all aspects of Phase I – III clinical trials including pharmacokinetics in healthy volunteers, bio-availability and bio-equivalence studies, drug metabolism studies, dose proportionality studies and multiple dose studies.
More info >> |
|
|
